Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

被引:29
作者
Xu, Lijuan [1 ]
Wan, Xuesi [1 ]
Huang, Zhimin [1 ]
Zeng, Fangfang [2 ]
Wei, Guohong [1 ]
Fang, Donghong [1 ]
Deng, Wanping [1 ]
Li, Yanbing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China
关键词
GLOMERULAR-FILTRATION-RATE; TYPE-2; DIABETIC-PATIENTS; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; NONDIABETIC NEPHROPATHIES; DOUBLE-BLIND; D-RECEPTOR; PARICALCITOL; ALBUMINURIA; PROTEINURIA;
D O I
10.1371/journal.pone.0061387
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. Design: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. Results: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, -0.10; 95% CI, -0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. Conclusions: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found.
引用
收藏
页数:14
相关论文
共 50 条
[41]   Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease [J].
Ketteler, Markus ;
Ambuhl, Patrice .
JOURNAL OF NEPHROLOGY, 2021, 34 (05) :1405-1418
[42]   Adjunctive Active Vitamin D Decreases Kidney Function during Treatment of Secondary Hyperparathyroidism with Extended-Release Calcifediol in Non-Dialysis Chronic Kidney Disease in a Randomized Trial [J].
Ashfaq, Akhtar ;
Choe, John ;
Strugnell, Stephen A. ;
Patel, Nilay ;
Sprague, Stuart M. ;
Norris, Keith C. ;
Lerma, Edgar ;
Petkovich, P. Martin ;
Bishop, Charles W. .
AMERICAN JOURNAL OF NEPHROLOGY, 2025, :490-499
[43]   Testosterone Supplementation in Patients With Chronic Heart Failure: A Meta-Analysis of Randomized Controlled Trials [J].
Tao, Jianping ;
Liu, Xiaoyong ;
Bai, Wenwei .
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[44]   Efficacy of probiotics/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials [J].
Liu, Chang ;
Yang, Letian ;
Wei, Wei ;
Fu, Ping .
FRONTIERS IN NUTRITION, 2024, 11
[45]   The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials [J].
Gao, Hong ;
Li, YanTao ;
Yan, WenNan ;
Gao, Fei .
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2021, 2021
[46]   Influence of vitamin D supplementation on lipid levels in polycystic ovary syndrome patients: a meta-analysis of randomized controlled trials [J].
Jin, Bihui ;
Qian, Lingbo ;
Fu, Xiaohua ;
Zhu, Jing ;
Shu, Jing .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (08)
[47]   The effects of vitamin D supplementation on inflammatory biomarkers in patients with asthma: a systematic review and meta-analysis of randomized controlled trials [J].
El Abd, Asmae ;
Dasari, Harika ;
Dodin, Philippe ;
Trottier, Helen ;
Ducharme, Francine M. .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[48]   Effects of vitamin D on serum lipid profile in patients with type 2 diabetes: A meta-analysis of randoMized controlled trials [J].
Jafari, Tina ;
Fallah, Aziz A. ;
Barani, Afshin .
CLINICAL NUTRITION, 2016, 35 (06) :1259-1268
[49]   Antiproteinuria Effect of Calcitriol in Patients With Chronic Kidney Disease and Vitamin D Deficiency: A Randomized Controlled Study [J].
Wu, Chia-Chao ;
Liao, Min-Tser ;
Hsiao, Po-Jen ;
Lu, Chien-Lin ;
Hsu, Yu-Juei ;
Lu, Kuo-Cheng ;
Chu, Pauling .
JOURNAL OF RENAL NUTRITION, 2020, 30 (03) :200-207
[50]   Dietary Salt Restriction in Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials [J].
Garofalo, Carlo ;
Borrelli, Silvio ;
Provenzano, Michele ;
De Stefano, Toni ;
Vita, Carlo ;
Chiodini, Paolo ;
Minutolo, Roberto ;
De Nicola, Luca ;
Conte, Giuseppe .
NUTRIENTS, 2018, 10 (06)